Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFARM LIMITED Director's Dealing 2014

Nov 13, 2014

65453_rns_2014-11-13_6a2a8b2d-b31a-4fde-8944-dd1e5506fafd.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director WILLIAM BRUCE GOODFELLOW
Date of last notice 9/5/2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Sulkem Company Ltd
Date of change 14/11/2014
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Direct:
111,641 Fully Paid Ordinary Shares
Indirect:
Pacific Custodians Pty Ltd – 31,585 Fully Paid
Ordinary Shares
MA Goodfellow – 13,000 Fully Paid Ordinary Shares
and 100 NSS
St Kentigern Trust – 430,434 Fully Paid Ordinary
Shares and 19,727 NSS
Sulkem Company Ltd – 123,171 Fully Paid Ordinary
Shares
Auckland Medical Research Foundation – 26,558
NSS
Trustees of The Goodfellow Foundation – 33,854
Fully Paid Ordinary Shares and 1,338
NSS
WB Goodfellow and Edgar William Preston as
Trustees of the 531 Trust – 400,861 Fully
Paid Ordinary Shares
Archem Trading (NZ) Ltd - 700 NSS
Class Ordinary
Number acquired Direct: 329 Fully Paid Ordinary Shares
Indirect: (Sulkem Company Ltd) 1,296 Fully Paid
Ordinary Shares
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
$4.8033
No. of securities held after change Direct:
111,970 Fully Paid Ordinary Shares
Indirect:
Pacific Custodians Pty Ltd – 31,585 Fully Paid
Ordinary Shares
MA Goodfellow – 13,000 Fully Paid Ordinary Shares
and 100 NSS
St Kentigern Trust – 430,434 Fully Paid Ordinary
Shares and 19,727 NSS
Sulkem Company Ltd – 124,467 Fully Paid Ordinary
Shares
Auckland Medical Research Foundation – 26,558
NSS
Trustees of The Goodfellow Foundation – 33,854
Fully Paid Ordinary Shares and 1,338
NSS
WB Goodfellow and Edgar William Preston as
Trustees of the 531 Trust – 400,861 Fully
Paid Ordinary Shares
Archem Trading (NZ) Ltd - 700 NSS
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Shares Issued under the Company’s Dividend Reinvestment Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3